Vela Genomics for Powerful Next-Generation Sequencing (NGS) Clinical Reporting
TheraKey™ by Vela Genomics provides Accurate Clinical Interpretation and Reporting for high-throughput NGS somatic oncology testing. The powerful solution transforms rich genomics profiling data into clinically actionable outcomes. TheraKey™ is compatible with any NGS instrument to provide information beyond the standard reporting. It saves costs and accelerate TAT by saving time spent on manually researching and cross referencing all information from various database. We aim to assist clinicians in expanding their cancer patient’s treatment options, empowering precision medicine in healthcare.
Learn More About TheraKey™TheraKey™ Interpretation Report for Accurate Matching of Patient-to-Treatments



